Multifocal Fixed Drug Eruption with COX-2 Inhibitor-Celecoxib

Cyclooxygenase-2 (COX-2) inhibitors are rapidly becoming the first choice nonsteroidal anti-inflammatory drugs (NSAIDs) for various rheumatological and other painful conditions. However, they might not be as safe or free of side effects as they are considered to be. These COX-2inhibitors may cause a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chugh, Shikha, Sarkar, Rashmi, Garg, Vijay K, Singh, Avninder, Keisham, Chitralekha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657214/
https://www.ncbi.nlm.nih.gov/pubmed/23716804
http://dx.doi.org/10.4103/0019-5154.108057
Descripción
Sumario:Cyclooxygenase-2 (COX-2) inhibitors are rapidly becoming the first choice nonsteroidal anti-inflammatory drugs (NSAIDs) for various rheumatological and other painful conditions. However, they might not be as safe or free of side effects as they are considered to be. These COX-2inhibitors may cause a variety of dermatological and systemic side effects of which we should be aware to avoid their indiscriminate use. We hereby report a case of multifocal fixed drug eruption (FDE) with celecoxib which has not yet been reported in Indian settings.

Ejemplares similares